170 related articles for article (PubMed ID: 28969784)
21. The efficacy of a topical formulation of selamectin plus sarolaner in preventing the development of a macrocyclic lactone-resistant strain of Dirofilaria immitis in cats.
Pullins A; McTier TL; Mahabir S; DeRose G; Hedges L
Vet Parasitol; 2020 Jun; 282():109122. PubMed ID: 32460111
[TBL] [Abstract][Full Text] [Related]
22. Development of rapid in vitro colorimetric enzymatic activity assay to differentiate macrocyclic lactone susceptible and resistant Dirofilaria immitis isolates.
Curry E; Prichard R
Vet Parasitol; 2022 Apr; 304():109696. PubMed ID: 35305421
[TBL] [Abstract][Full Text] [Related]
23. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
[TBL] [Abstract][Full Text] [Related]
24. Evidence for macrocyclic lactone anthelmintic resistance in Dirofilaria immitis.
Geary TG; Bourguinat C; Prichard RK
Top Companion Anim Med; 2011 Nov; 26(4):186-92. PubMed ID: 22152606
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism in ion channel genes of Dirofilaria immitis: Relevant knowledge for future anthelmintic drug design.
Mani T; Bourguinat C; Keller K; Carreton E; Peregrine A; Prichard RK
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):343-355. PubMed ID: 27682347
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis.
Martin EM; Mitchell EB; Yoon S; McCall JW; Fankhauser B; Mansour A; McCall S; Pollmeier M
Parasit Vectors; 2024 Apr; 17(1):176. PubMed ID: 38575969
[TBL] [Abstract][Full Text] [Related]
27. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?
Prichard RK
Vet Parasitol; 2005 Oct; 133(2-3):243-53. PubMed ID: 16198824
[TBL] [Abstract][Full Text] [Related]
28. Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype.
Bourguinat C; Keller K; Blagburn B; Schenker R; Geary TG; Prichard RK
Vet Parasitol; 2011 Mar; 176(4):374-81. PubMed ID: 21300438
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ivermectin against third-stage Dirofilaria immitis larvae in ferrets and dogs.
Blair LS; Williams E; Ewanciw DV
Res Vet Sci; 1982 Nov; 33(3):386-7. PubMed ID: 6897584
[TBL] [Abstract][Full Text] [Related]
30. Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro.
Vatta AF; Dzimianski M; Storey BE; Camus MS; Moorhead AR; Kaplan RM; Wolstenholme AJ
Vet Parasitol; 2014 Nov; 206(1-2):38-42. PubMed ID: 24594213
[TBL] [Abstract][Full Text] [Related]
31. Genotyping USA laboratory-maintained isolates and European clinical isolates of Dirofilaria immitis to assess macrocyclic lactone susceptibility or resistance at predictive SNP sites using droplet digital PCR.
Kumar S; Che H; Chiummo R; Heuer L; Schneider C; Werr M; Guerino F; Papadopolous E; Diakou A; Mihalca AD; Traversa D; Di Cesare A; Long T; Prichard RK
Vet Parasitol; 2024 Jun; 328():110181. PubMed ID: 38582015
[TBL] [Abstract][Full Text] [Related]
32. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease.
Prichard RK
Int J Parasitol; 2021 Dec; 51(13-14):1121-1132. PubMed ID: 34717929
[TBL] [Abstract][Full Text] [Related]
33. Secretory microRNA Profiles of Third- and Fourth-Stage
Tritten L; Burkman EJ; Clark T; Verocai GG
Pathogens; 2021 Jun; 10(7):. PubMed ID: 34206439
[TBL] [Abstract][Full Text] [Related]
34. Investigating Dirofilaria immitis isolates infecting domestic canines and their susceptibility/resistance patterns to macrocyclic lactones in the northern region of the Mississippi Delta area (southeast Missouri).
Fisher PT; Keller K; Prichard RK
Vet Parasitol; 2024 Jul; 329():110199. PubMed ID: 38781830
[TBL] [Abstract][Full Text] [Related]
35. Macrocyclic lactone resistance in Dirofilaria immitis.
Bourguinat C; Keller K; Bhan A; Peregrine A; Geary T; Prichard R
Vet Parasitol; 2011 Sep; 181(2-4):388-92. PubMed ID: 21570194
[TBL] [Abstract][Full Text] [Related]
36. Using population genetics to examine relationships of Dirofilaria immitis based on both macrocyclic lactone-resistance status and geography.
Sanchez J; Dharmarajan G; George MM; Pulaski C; Wolstenholme AJ; Gilleard JS; Kaplan RM
Vet Parasitol; 2020 Jul; 283():109125. PubMed ID: 32535487
[TBL] [Abstract][Full Text] [Related]
37. Concern for
Diakou A; Prichard RK
Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684273
[No Abstract] [Full Text] [Related]
38. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
[TBL] [Abstract][Full Text] [Related]
39. A rodent model for Dirofilaria immitis, canine heartworm: parasite growth, development, and drug sensitivity in NSG mice.
Hess JA; Eberhard ML; Segura-Lepe M; Grundner-Culemann K; Kracher B; Shryock J; Harrington J; Abraham D
Sci Rep; 2023 Jan; 13(1):976. PubMed ID: 36653420
[TBL] [Abstract][Full Text] [Related]
40. Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States.
Bowman DD
Parasit Vectors; 2012 Jul; 5():138. PubMed ID: 22776618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
